Global AI Signs Enterprise Contract with One of the World’s Largest Pharmaceutical Companies to Automate Compliance Operations

Core Insights - Global AI Inc. has signed a contract with a major pharmaceutical and life sciences company to automate compliance-critical and data-intensive business processes using its AI-driven solutions [1][2]. Group 1: Contract Details - The agreement involves deploying the enterprise-grade Agentic AI Platform to enhance regulatory monitoring, compliance reporting, and internal HR operations, which require high accuracy and traceability [2]. - The platform's compliance automation capabilities ensure full auditability and governance throughout the reporting lifecycle, tailored to meet the standards of global pharmaceutical organizations [3]. Group 2: Company Perspective - Darko Horvat, Chairman and CEO of Global AI, emphasized that the deployment of agentic AI products in the pharmaceutical sector showcases the company's enterprise-scale capabilities and builds credibility for broader adoption across various business processes [4]. - Global AI is recognized as a leader in AI agentic products, providing secure and high-performance solutions that enhance decision-making and create measurable shareholder value [4].